Expert Tips and Cancer Resources
12/1/2023
In a new interview, Providence CORE researcher Monique Gill discusses CORE’s research on the links between healthcare experiences and engagement with mammography.
11/20/2023
A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.
11/9/2023
JACC earned re-accreditation for stem cell therapy treatment program.
11/3/2023
Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.
11/20/2023
SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.
10/27/2023
Genetic testing can help you learn your risk for cancer early, when you can better fight it. One mom credits genetic testing with saving her life.
10/20/2023
Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.
10/18/2023
Breast surgeon Lorena Gonzalez, MD, is a trusted adviser to patients, in part because she’s been in their shoes. Here she shares key information women should know.
10/12/2023
Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.
10/18/2023
A recent study found an increased prevalence of cancer in people under 50. The study noted increases of endocrine, gastrointestinal and breast cancers in people between the ages of 30 and 39.
10/5/2023
Radiofrequency ablation: Cancer diagnosis leads to life-improving procedure
10/16/2023
"I found my passion early in my career. I had to educate and improve myself so I could help patients understand their diagnosis and be able to make better decisions about their care."
10/4/2023
Providence Cancer Institute of Oregon, and research director, Earle A. Chiles Research Institute, Walter J. Urba, M.D., Ph.D., receives award for his contributions to science and community.
9/28/2023
Learn if you may be at risk of ovarian cancer — and what you can do to reduce your risk of this disease.
9/25/2023
Providence Cancer Institute celebrates Advanced Practice Providers Week from September 25 to 29 and recognizes their important contributions more than 25 clinics and programs.
9/22/2023
Providence Swedish is at the forefront of new technologies that decrease pain and shorten recovery time for prostate cancer patients.
9/22/2023
Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.
9/13/2023
While rates of lung cancer have dropped with successful campaigns to curb smoking, lung cancer remains a problem – including for non-smokers. Learn how.
9/18/2023
For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.
8/18/2023
New trial open at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, is enrolling patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma.
8/9/2023
What’s in your DNA matters. From your risk for developing certain diseases to what treatments might work best for you, it’s all written in your genes.
8/16/2023
A global study co-authored by Providence researchers shows significant promise for the treatment of Chronic lymphocytic leukemia/Small Lymphocytic Lymphoma
8/16/2023
World Lung Cancer Day is a time to support those living with lung cancer and work to prevent it in the future. See how Providence is recognizing this day.
7/10/2023
A phase II trial tests FOLFOX or CAPOX versus FOLFIRINOX in patients with locally advanced rectal cancer, and a phase I trial evaluates TBio-4101 in patients with advanced solid tumors.
7/3/2023
Final outcomes from a Providence Cancer Institute-sponsored phase Ib trial evaluating pembrolizumab with either weekly paclitaxel or flat-dose capecitabine in treating patients with metastatic TNBC.
6/28/2023
Researchers from Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, shared their investigations to advance cancer research and treatments at the premier event.
6/14/2023
Providence's Pavilion for Women and Children is hosting a Women's Wellness Day Cancer Screening event on July 15th.
6/5/2023
More than ever, cancer is a disease that people survive. From the day we meet you, your survivorship is the goal we have in mind as we develop and deliver your personalized treatment plan. Once your t
